Country adaptation of health economic models, without rebuilding them.
I localise the inputs and methods of a global model to the reference case of each HTA body, so it meets local requirements and keeps its clinical logic.
One global model, every local requirement.
A global model rarely follows each country's guideline: perspective, comparators, costs, utilities, discounting and presentation all differ. Rebuilding it for each market is expensive.
I localise the inputs and the methods to the local reference case, so the model meets local requirements without being rebuilt.
The approach follows the published transferability frameworks: what can be kept from the global model, what must change, and how to document the choice.
The result is a model and a justification that an assessor can follow.
Where I adapt models.
France
Economic evaluation guideline of the French HTA body, with its efficiency opinion, and budget impact methods for price negotiation.
England
NICE health technology evaluations manual, its reference case, and resource impact assessment.
United States
ICER value assessment framework and the AMCP format for formulary submissions, with budget impact for payers.
Switzerland
FOPH criteria of efficacy, appropriateness and cost-effectiveness (WZW), and the federal HTA programme.
Japan
C2H guideline for cost-effectiveness evaluations submitted in Japan.
Canada
CDA-AMC and INESSS submissions, with the Canadian budget impact analysis guidelines.
Beyond translation.
- Perspective and costs. Payer or societal perspective, local unit costs and tariffs.
- Comparators and practice. Treatments actually used in the country.
- Population and epidemiology. Local patient numbers and characteristics.
- Utilities. Health-state values from the value set the agency expects.
- Discounting and horizon. Rates and time horizons required by the local guideline.
- Presentation. Results, scenarios and documentation in the format the agency reads.
Transferability first, then adaptation.
The frameworks used include the ISPOR transferability task force, the Welte and Boulenger checklists, the EUnetHTA adaptation toolkit and the global model adaptation strategies.
Scoping
Global model, target country, guideline, deadline.
Transferability review
Which parameters can be kept and which must vary, using the published frameworks.
Adaptation
Inputs, structure and scenarios localised and documented.
Check and handover
Quality check of the adapted model, technical note and walkthrough.
Questions and answers
What is model adaptation to a country?
Adjusting a global health economic model so that it follows the requirements of a local HTA body: its perspective, comparators, costs, utilities, discounting, presentation and evidence rules.
Is it faster than building a new model?
Usually yes. The global model keeps its structure and clinical logic. Only what the local guideline requires is changed, and the choices are documented.
Which countries do you cover?
France, England, the United States, Switzerland, Japan and Canada. Other countries can be scoped on request.
Do you also check the adapted model?
Yes. The adapted model can go through a quality check before submission.
Can you adapt a model that another consultancy built?
Yes, as long as the model file and its documentation are shared. An NDA can be signed first.
Let's talk about your project.
A 30-minute call, at a time that suits you. Prefer 15 minutes or 1 hour?
Contact